News

Displaying 1 - 20 of 30

Gaps in HIV prevention expose Europe to risk of outbreaks

01.12.2014

In Europe, decades of investment in effective HIV prevention measures targeting people who inject drugs continue to bear fruit as demonstrated by the long-term decline in HIV diagnoses related to drug injecting. Over the past ten years, the rate of newly reported HIV diagnoses attributed to...

Annual award ceremony to celebrate excellence in scientific writing on illicit drugs

24.11.2014

The four winners of the 2014 EMCDDA scientific paper award will be honoured in Lisbon on 25 November at the fourth annual award ceremony hosted by the EU agency (1). The winners will receive a non-monetary prize for their contributions in the margins of the third ‘Reitox week’ initiative, which...

Third EMCDDA Reitox week

19.11.2014

Candidate, potential candidate and neighbouring countries of the EU, preparing to collaborate with the EMCDDA, will participate in the third ‘Reitox week’ to be held in Lisbon from 25–28 November. This annual event, initiated in 2012 and enlarging the regular Heads of focal point session, will...

Pregnancy and opioid use: strategies for treatment

14.11.2014

Illicit opioid consumption is associated with an increase in obstetric complications in pregnant women. It also brings with it a range of potential dangers for the child, both before and after birth. Neonatal complications include narcotic withdrawal, postnatal growth deficiency, microcephaly,...

Click and learn with the EMCDDA’s new-look Best practice portal

23.10.2014

Real-life responses to drug problems come under the spotlight today as the EU drugs agency (EMCDDA) launches its revamped Best practice portal (1). Designed as a practical and reliable source of what works, and what doesn’t, in the areas of drug-related prevention, treatment, harm reduction and...

Drug-related harms and responses in focus at annual EMCDDA expert meetings

13.10.2014

Latest evidence in the area of drug overdose, HCV infections and HIV outbreaks among drug users will be among the topics discussed in a series of events unfolding this week at the EU drugs agency (EMCDDA) in Lisbon (1). Two EMCDDA expert meetings, dedicated to the agency’s drug-related deaths and...

Second EMDAS graduation ceremony at EMCDDA

29.09.2014

The second group of 25 students graduating from the European Masters in Drug and Alcohol Studies (EMDAS), will receive their diplomas at a ceremony at the EMCDDA on 30 September (1). EMDAS, a project initially funded through the EC-Lifelong Learning Programme, involves three European universities:...

Four new drugs to be placed under control

25.09.2014

Today, EU Ministers adopted a European Commission proposal to control four new psychoactive substances currently raising health concerns in Europe. With today's decision, the substances MDPV, methoxetamine, AH-7921, and 25I-NBOMe will be subject to control measures and criminal penalties...

EMCDDA unites expert networks in integrated approach to monitoring

24.09.2014

‘Continuity and change: high-risk drug use and drug treatment in Europe’, is the focus of events unfolding this week at the EU drugs agency (EMCDDA) in Lisbon (1). Two parallel EMCDDA expert meetings, dedicated to the agency’s treatment demand indicator (TDI) and the problem drug use indicator (...

European Parliament President Martin Schulz to visit EU agencies in Lisbon

19.09.2014

EMSA Director Markku Mylly, European Parliament Martin Schulz, EMCDDA Director Wolfgang Götz (click to see more photos on Flickr.com Newly re-elected President of the European Parliament Martin Schulz will visit the EU drugs agency (EMCDDA) and the European Maritime Safety Agency (EMSA) on 23...

ECDC-EMCDDA mission on HIV status and hepatitis surveillance in Latvia

03.09.2014

At the invitation of the Latvian government, and in the context of high HIV levels in the country, ECDC and the EMCDDA have joined forces to assist national experts in preventing and controlling infectious diseases among different risk groups, including people who inject drugs. Six experts from the...

Published today on World Hepatitis Day: New EMCDDA review on hepatitis C virus infection among people who inject drugs in Europe

28.07.2014

People who inject drugs (PWID) are a key population affected by the hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. To coincide with World Hepatitis Day, the open-access online journal PLOS ONE publishes the results of an...

Eurojust and EMCDDA pledge to boost cooperation

15.07.2014

Exchanging strategic and technical information in the areas of drug legislation and supply was among the pledges made today in a Memorandum of Understanding (MoU) signed by the EU drugs agency (EMCDDA) and the EU judicial cooperation unit (Eurojust). At an official ceremony in The Hague, EMCDDA...

Third European drugs summer school opens today in Lisbon

30.06.2014

The third European drugs summer school (EDSS) — ‘Illicit drugs in Europe: demand, supply and public policies’ — opens today in Lisbon and will run until 11 July. The initiative, organised by the University Institute of Lisbon (ISCTE) and the EU drugs agency (EMCDDA), is supported by the US National...

26 June: International day against drug abuse and illicit trafficking

25.06.2014

An estimated 28 000 lives are lost on Europe’s roads every year and a further 1.34 million people are injured (1). Many of these accidents and deaths are caused by drivers whose performance is impaired by a psychoactive substance. Alcohol remains the number one substance endangering lives on...

EU drugs agency places six topics in the spotlight with new online analyses

27.05.2014

The EU drugs agency (EMCDDA) releases today alongside its European Drug Report 2014: Trends and developments, six new additions to its Perspectives on drugs (PODs) series. This latest selection of online, interactive analyses provides a state-of-the-art review of key aspects of the European drug...

European Drug Report out today — Europe’s drugs problem ‘increasingly complex’

27.05.2014

Europe’s drugs problem is becoming increasingly complex with new challenges emerging that raise concerns for public health. This is according to the European Drug Report 2014: Trends and developments released today by the EU drugs agency (EMCDDA) in Lisbon (1). In its annual review of the drugs...

Largest multi-city study on drug wastewater analysis released today

27.05.2014

The findings of the largest European project to date in the emerging science of wastewater analysis (WWA) are released today in an article published in Addiction (1). The project in question — steered by the Europe-wide SCORE network (2) — analysed wastewater in over 40 European cities to explore...

International experts to examine latest findings in the field of new drugs

15.05.2014

International experts gather in Rome today to examine the latest scientific research in the rapidly-changing field of novel (or new) psychoactive substances (NPS). They will be participating in the Third international conference on novel psychoactive substances organised by: the University of...

EU drugs agency to launch European Drug Report 2014

24.04.2014

The EU drugs agency (EMCDDA) will be presenting its annual overview of the European drug situation on 27 May in a multilingual, multimedia information package focusing on today’s rapidly shifting drug phenomenon. Central to the package is the European Drug Report 2014: Trends and developments (in...
Loading